Sign in to view content

Multicenter Randomized Sham-Controlled Double-Masked Phase 2b Clinical Trial of Multi-Characteristic Opsin in Patients With Advanced Retinitis Pigmentosa

Peter K. Kaiser, MD FASRS

Video
Published 2022

Related

Suprachoroidally delivered gene therapy via non-viral DNA nanoparticles
Christine Kay, MD
On Demand Cases, Courses, and Papers
2019
Biodistribution of Suprachoroidal Drug and Viral Vector Delivery Across Animal Models and Human Trials
Glenn C. Yiu, MD, PhD
Annual Meeting Talks
2022
Hereditary Retinal Disease & Genetics Take-Home Panel
David Sarraf, MD
Annual Meeting Talks
2019

Category: Hereditary Retinal Disease & Genetics

See more